Grifols prepares for late-stage plans with plasma-derived medicines in 2024
In an interview with Pharmaceutical Technology, the company’s chief scientific officer detailed the company’s upcoming 2024 plans.
Treatments
Evotec partners with Crohn’s & Colitis Foundation for IBD therapies
3M Health receives grant to develop wound treatment solutions in US
Boehringer and Kyowa Kirin sign fibro-inflammatory treatment deal
BMS bags advanced melanoma win for Opdualag in the UK
Sosei wins South Korean approval for brain injury drug
Leading innovators in amyloid precursor targeted therapies for the pharmaceutical industry
Genomics: the leading companies in anti-sense oligonucleotides revealed
